AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Phase II vaccine efficacy trials set to begin.
2002 NOV 13 - (NewsRx.com & NewsRx.net) -- Antex Biologics, Inc., (AMEX:ANX) announced that two phase II trials for its Helivax vaccine against Helicobacter pylori, a bacterial pathogen responsible for peptic ulcers and stomach cancers, are scheduled to begin shortly.
One trial will assess the preventive properties of the vaccine while the other trial will assess the vaccine's therapeutic capabilities. Both trials will be conducted in a randomized open label manner and will include a total of 80 patients in multiple sites throughout the United States.
The Helivax vaccine was developed using the company's patented Nutriment Signal Transduction (NST) technology. The company has patents issued and pending claiming composition of matter and methods of using the vaccine, including for both prophylactic and therapeutic indications in humans.
The phase II trials will focus on mucosal immune responses elicited by the vaccine as correlates of protection and on the vaccine's ability to reduce the H. pylori bioburden in infected subjects. Reducing the level of H. pylori in infected individuals will be used to evaluate Helivax as a therapeutic vaccine.
Antex has conducted a thorough preclinical evaluation of Helivax ...
- Antex Granted Two Additional Patents; Proprietary Position on Nutriment Signal...
- Press release article from: PR Newswire October 14, 1998 700+ words
...announced today that the United States Patent and Trademark Office has allowed two more patents on Antex's NST(TM) ("Nutriment Signal Transduction") platform technology. The claims of these two patents broadly cover the vaccines for Shigella and Campylobacter...
- Antex Biologics Receives Patent for Helicobacter Pylori Vaccine.
- Press release article from: PR Newswire April 26, 2000 700+ words
...s proprietary NST(TM) (Nutriment Signal Transduction) technology...I carcinogen. The American Cancer Society estimates that there are over...deaths per year. NST(TM) (Nutriment Signal Transduction) is an innovative...
- Efficacy trials will assess prophylactic and therapeutic indications.
- Newspaper article from: Biotech Week November 6, 2002 700+ words
...Helivax vaccine was developed using the company's patented nutriment signal transduction (NST) technology. The company has patents...Health Organization as a Type I carcinogen. The American Cancer Society estimates there are more than 25,000 new cases of stomach...
- Oral Vaccine Trial Begins.
- Newspaper article from: TB & Outbreaks Week August 8, 2000 700+ words
...Health Organization as a Type I carcinogen. The American Cancer Society estimates that there are over 25,000 new cases of stomach...Helivax is produced using the company's proprietary NST (Nutriment Signal Transduction) technology. This patented technology is...
- Antex Announces Clinical Results of H. Pylori Vaccine.
- Press release article from: PR Newswire August 22, 2001 700+ words
...Helicobacter pylori vaccine produced using the Company's Nutriment Signal Transduction (NST) technology. The objectives of the...Health Organization as a Type I carcinogen. The American Cancer Society estimates there are more than 25,000 new cases of stomach...
- Phase II vaccine efficacy trials set to begin.
- Newspaper article from: Biotech Week November 13, 2002 700+ words
...Helivax vaccine was developed using the company's patented Nutriment Signal Transduction (NST) technology. The company has patents...Health Organization as a type I carcinogen. The American Cancer Society estimates there are over 25,000 new cases of stomach cancer...
- Oral Vaccine Trial Begins.(Antex Biologics begins Helivax oral vaccine...
- Newspaper article from: Vaccine Weekly August 9, 2000 700+ words
...Health Organization as a Type I carcinogen. The American Cancer Society estimates that there are over 25,000 new cases of stomach...Helivax is produced using the company's proprietary NST (Nutriment Signal Transduction) technology. This patented technology is...
- Oral Vaccine Trial Begins.(for Antex Biologics' Helivax vaccine for...
- Newspaper article from: Immunotherapy Weekly August 9, 2000 700+ words
...Health Organization as a Type I carcinogen. The American Cancer Society estimates that there are over 25,000 new cases of stomach...Helivax is produced using the company's proprietary NST (Nutriment Signal Transduction) technology. This patented technology is...
